Obesity is a heterogeneous chronic disease that requires diagnostic, behavioral, and life-stage-specific approaches beyond body mass index-centered assessment. In this short communication, the 5 invited speakers’ presentations from the Daeat Conference 2026 were reviewed and the content was organized into 4 research domains for Korean medicine (KM) obesity care. These were (1) interpretable diagnosis; (2) digital phenotyping and hybrid care; (3) life-stage-specific management; and (4) response-based personalization. Interpretable diagnosis was framed as a proposed modeling approach which maps multidimensional clinical observations onto inspectable diagnostic structures. Digital phenotyping was considered as a means of extending behavioral measurement beyond clinical consultations while preserving clinician-led care. Life-stage-specific management emphasized sarcopenic obesity and functional outcomes in older adults, while highlighting growth, development, and evidence gaps in children and adolescents. Response-based personalization distinguished nutritional input from interindividual metabolic and behavioral variability. Across these domains, several priorities for future research emerged, including standardized outcomes, longitudinal data, pragmatic multicenter studies, and appropriate data governance. These themes represent potential research directions rather than established evidence of clinical effectiveness.
Background Generative artificial intelligence (GenAI) chatbots can simulate conversations and perform tasks typically performed by humans, and offer novel research opportunities. Specifically, GenAI chatbots have shown utility in assisting with literature reviews, and interpreting large datasets, among other labor-intensive tasks. Traditional, complementary, and integrative medicine (TCIM) is a patient-centric approach that emphasizes holistic well-being. The integration of TCIM and artificial intelligence (AI) presents numerous key opportunities. However, TCIM researchers’ attitudes and perceptions of the role of GenAI tools in the scientific process remain less understood.
Methods This protocol for a large-scale, international cross-sectional web-based survey was designed to elucidate the attitudes and perceptions of TCIM researchers regarding the use of GenAI chatbots in the research process. Emphasis will be placed on the advantages, limitations, and the ethical implications of GenAI chatbots use. The survey will be sent to TCIM researchers who have previously published in the field (anticipated 3%-7% response rate). It will include questions regarding demographic information, familiarity with AI chatbots, perceived benefits, and challenges of AI chatbots in the scientific process, and it will have several open-ended questions. Data will be analyzed using descriptive statistics.
Conclusion By developing a deeper understanding of TCIM researchers' perspectives, future AI applications in this field can be more informed, enabling greater trust and acceptance surrounding the use of GenAI. Furthermore, findings from this survey will be integral to gaining insight into the perceived challenges of TCIM-driven AI, which will be vital in guiding future policies and collaborations among researchers.
Citations
Citations to this article as recorded by
Ethics in the age of artificial intelligence: reflections from mapping the terrain and implications for traditional, complementary, and integrative medicine Jeremy Y. Ng Journal of Complementary and Integrative Medicine.2026; 23(2): 201. CrossRef
Attitudes and Perceptions of Generative Artificial Intelligence Chatbots in the Scientific Process of Traditional, Complementary, and Integrative Medicine Research: A Large‐Scale, International Cross‐Sectional Survey Jeremy Y. Ng, Jamie Tan, Niveen Syed, Karthik Adapa, Prashant Kumar Gupta, Shao Li, Darshan Mehta, Melinda Ring, Manisha Shridhar, Joao Paulo Souza, Tetsuhiro Yoshino, Myeong Soo Lee, Holger Cramer Journal of Evidence-Based Medicine.2026;[Epub] CrossRef